[Pharmaceutical Company]
Bringing a vision to life — building our own pharmaceutical company
Our pharmaceutical company, part of the Concentration Group, was born from two driving forces: deep expertise in the pharmaceutical market and a personal professional dream of one of our founders — Alexander Panov.
For the Group, this is a natural next step: not only to supply the industry with essential products, but also to create our own pharmaceutical solutions.
Our portfolio brings together the following therapeutic areas and directions:
Central Nervous System (CNS)
Antidepressants, antipsychotics, selective serotonin receptor agonists.
Oncology
Products used in oncotherapy to reduce toxicity and enhance the efficacy of anticancer agents.
Dermatology
Products for treatment and care in dermatology.
Women's Health
Products for women's health.
Our products are manufactured at contract facilities operated by our Russian partners. At the same time, we are developing our own production site and R&D center.
Our products are at various stages of the lifecycle: development, technology transfer, clinical trials, and registration. The launch of our first product is planned for mid-2027.
FDF 1
FDF 2
FDF 3
FDF 4
FDF 5
FDF 6